Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2024

Stockholders' Equity Note [Abstract]

Schedule of Stock Option Activity

A summary of employees’ stock options activities during the nine months ended September 30, 2024 is as follows:

 

	Nine Months Ended September 30, 2024 (unaudited)
	Number	Weighted average exercise price		Aggregate intrinsic value (in thousands)		Weighted average remaining contractual life (years)
Options outstanding as of January 1, 2024	573,430	$	7.564	$	21,627	0.962
Granted	—	$	—
Exercised	(570,064)	$	7.575
Forfeited and expired	—	$	—
Options outstanding and exercisable as of September 30, 2024	3,366	$	5.682	$	171	5.368

Schedule of Share-based Payment Arrangement, Restricted Stock Unit and Performance Stock Unit Activity

A summary of RSUs and PSUs for employees, consultants and non-employee directors of the Company for the nine months ended September 30, 2024 (unaudited) is as follows:

 

	Number of shares underlying outstanding RSUs and PSUs	Weighted- average grant date fair value
Unvested balance - January 1, 2024	8,234,171	$	36.83
Granted	3,642,369	$	42.95
Vested	(3,124,657)	$	40.12
Forfeited	(1,108,567)	$	38.79
Unvested balance – September 30, 2024	7,643,316	$	38.12

Schedule of Stock-Based Compensation Expense

The Company recognized stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):

 

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
	(unaudited)				(unaudited)
Cost of revenues	$	1,357	$	1,416	$	4,017	$	5,946
Research and development	10,442		11,323		31,057		37,480
Sales and marketing	9,860		11,201		30,985		37,861
General and administrative	10,272		9,040		28,054		26,889
Total	$	31,931	$	32,980	$	94,113	$	108,176